BioCentury
ARTICLE | Distillery Therapeutics

Cancer

February 21, 2018 7:16 PM UTC

Mouse studies suggest depleting asparagine with l-asparaginase or ASNS inhibition could help treat metastatic breast cancer. In an allogeneic mouse model of metastatic breast cancer, shRNA targeting A...

BCIQ Company Profiles

University of Cambridge

BCIQ Target Profiles

Asparagine synthetase (ASNS)